Please login to the form below

Not currently logged in
Email:
Password:

Disruptive technologies set to stabilise soaring drug prices

AI and blockchain could accelerate the drug development process, says report

robot

The pharmaceutical industry has been no stranger to the rising costs of drug development as of late, but disruptive technologies could soon change this paradigm, according to a report by GlobalData.

Artificial intelligence (AI), big data and blockchain are set to impact the industry, not only by helping to add value in terms of personalised treatments, but to also counteract the unsustainability of skyrocketing drug prices, according to the data and analytics company.

The report states that there are currently over 100 companies applying AI to healthcare, with big names such as Google, Microsoft, Amazon and IBM Watson paving the way.

With the new technology, researchers are hoping to “generate more accurate hypotheses faster, making the drug discovery process less expensive and more effective”, said Valentina Gburcik, GlobalData’s cardiovascular and metabolic disease director.

She added: “In addition, the database of electronic medical records and public health data can be analysed to identify hidden patterns that can lead to a quick identification of potential molecular targets for a disease.”

And it’s not just the pharmaceutical industry that is set to see the change either. Quite recently it was reported that health insurers are also testing blockchain’s capabilities in generating more accurate and reliable demographic data, such as health records.

Gburcik concluded: “Blockchain could be a platform for sharing electronic health records between various health organisations in a secure way, which would further facilitate research and speed up the drug development process.

“Furthermore, there is a great potential for using this technology in pharmaceutical supply chain, medical billing and anonymised patient record transmission.”

Article by
Gemma Jones

1st May 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics